We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+12.37%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$11.2B
AUM Growth
+$4.26B
Cap. Flow
+$3.37B
Cap. Flow %
30.06%
Top 10 Hldgs %
50.61%
Holding
1,169
New
360
Increased
131
Reduced
115
Closed
294
Avg Time Held Equity + Options
1.3 quarters
Top 10 Avg Time Held Equity + Options
0.9 quarters
Top 20 Avg Time Held Equity + Options
0.9 quarters
Avg Time Held Equity only
1.2 quarters
Top 10 Avg Time Held Equity only
0.9 quarters
Top 20 Avg Time Held Equity only
0.9 quarters

Top Buys

Rank Stock Value
1
PPD
PPD, Inc. Common Stock
PPD
+$645M
2
NUAN
Nuance Communications, Inc.
NUAN
+$539M
3
MXIM
Maxim Integrated Products
MXIM
+$525M
4
VER
VEREIT, Inc.
VER
+$520M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$491M

Top Sells

Rank Stock Value
1
VAR
Varian Medical Systems, Inc.
VAR
+$475M
2
RP
RealPage, Inc.
RP
+$281M
3
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
+$209M
4
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$170M
5
CLGX
Corelogic, Inc.
CLGX
+$160M

Sector Composition

Rank Sector Weight
1 Technology 26.69%
2 Healthcare 19.01%
3 Financials 14.31%
4 Real Estate 10.94%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
MDH.WS
776
DELISTED
MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
MDH.WS
$116K ﹤0.01%
+149,994
New +$90.7K
2021 Q2
0 quarters
ACII.WS icon
777
DELISTED
Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50
ACII.WS
$116K ﹤0.01%
99,996
– –
2021 Q1
1 quarter
TCACW
778
DELISTED
Tuatara Capital Acquisition Corporation Warrant
TCACW
$116K ﹤0.01%
+100,000
New +$77.8K
2021 Q2
0 quarters
SVOKW
779
DELISTED
Seven Oaks Acquisition Corp. Warrant
SVOKW
$116K ﹤0.01%
100,392
– –
2021 Q1
1 quarter
SCLEW
780
DELISTED
Broadscale Acquisition Corp. Warrant
SCLEW
$115K ﹤0.01%
+100,000
New +$98.6K
2021 Q2
0 quarters
GIGGW
781
DELISTED
GigCapital4, Inc. Warrant
GIGGW
$115K ﹤0.01%
+99,996
New +$93.4K
2021 Q2
0 quarters
LGACW
782
DELISTED
Lazard Growth Acquisition Corp. I Warrants
LGACW
$114K ﹤0.01%
+99,996
New +$107K
2021 Q2
0 quarters
ASAXW
783
DELISTED
Astrea Acquisition Corp. Warrant
ASAXW
$114K ﹤0.01%
174,994
– –
2021 Q1
1 quarter
DLCAW
784
DELISTED
Deep Lake Capital Acquisition Corp. Warrant
DLCAW
$113K ﹤0.01%
124,996
– –
2021 Q1
1 quarter
LUXAW
785
DELISTED
Lux Health Tech Acquisition Corp. Warrants
LUXAW
$112K ﹤0.01%
83,330
– –
2021 Q1
1 quarter
IQI icon
786
PUT
Invesco Quality Municipal Securities
IQI
$472M
$111K ﹤0.01%
+120,000
New +$1.59M
2021 Q2
0 quarters
MDAIW icon
787
Spectral AI Warrants
MDAIW
$5.56M
$111K ﹤0.01%
+133,333
New +$89.3K
2021 Q2
0 quarters
STPC.WS
788
DELISTED
Star Peak Corp II Warrants, each whole warrant exercisable for one share of Class A common stock at
STPC.WS
$111K ﹤0.01%
63,222
+38,223
+153% +$62.3K
2021 Q1
1 quarter
CPRI icon
789
PUT
Capri Holdings
CPRI
$1.72B
$110K ﹤0.01%
+16,100
New +$876K
2021 Q2
0 quarters
PHICW
790
DELISTED
Population Health Investment Co., Inc. Warrant
PHICW
$110K ﹤0.01%
99,996
– –
2021 Q1
1 quarter
PCPC.WS
791
DELISTED
Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75
PCPC.WS
$108K ﹤0.01%
49,998
– –
2021 Q1
1 quarter
STWD icon
792
PUT
Starwood Property Trust
STWD
$4.62B
$107K ﹤0.01%
+52,200
New +$1.33M
2021 Q2
0 quarters
SNRHW
793
DELISTED
Senior Connect Acquisition Corp. I Warrant
SNRHW
$107K ﹤0.01%
124,996
– –
2021 Q1
1 quarter
ENDP
794
PUT
DELISTED
Endo International plc
ENDP
$105K ﹤0.01%
+91,400
New +$524K
2021 Q2
0 quarters
EEM icon
795
CALL
iShares MSCI Emerging Markets ETF
EEM
$30.5B
$104K ﹤0.01%
+360,000
New +$19.6M
2021 Q2
0 quarters
YSAC.WS
796
DELISTED
Yellowstone Acquisition Company Warrants, each whole warrant exercisable for one share of Class A co
YSAC.WS
$103K ﹤0.01%
124,996
– –
2021 Q1
1 quarter
FEZ icon
797
CALL
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.15B
$101K ﹤0.01%
+450,000
New +$21.4M
2021 Q2
0 quarters
SAFE icon
798
PUT
Safehold
SAFE
$848M
$101K ﹤0.01%
+14,751
New +$1.31M
2021 Q2
0 quarters
SLCRW
799
DELISTED
Silver Crest Acquisition Corporation Warrant
SLCRW
$101K ﹤0.01%
124,996
– –
2021 Q1
1 quarter
OTRAW
800
DELISTED
OTR Acquisition Corp. Warrant
OTRAW
$101K ﹤0.01%
124,996
– –
2021 Q1
1 quarter
30 31
32
33 34

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q2 2021 Portfolio in Review

As of Q2 2021, UBS O'Connor held 1,169 positions worth $11.2B, up 61% from $6.94B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

UBS O'Connor deployed $3.37B of net new capital in Q2 2021, opening 360 new positions and adding to 131 existing holdings. Its largest new stake was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was MasTec, an estimated $7.65M trimmed.

  • UBS O'Connor's largest Q2 2021 buy was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.
  • UBS O'Connor added most to Maxim Integrated Products in Q2 2021, an estimated $525M increase.
  • UBS O'Connor's biggest Q2 2021 reduction was MasTec, cutting an estimated $7.65M.
  • UBS O'Connor fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $475M.
  • UBS O'Connor's ten largest holdings make up 51% of its $11.2B portfolio in Q2 2021.
  • UBS O'Connor opened 360 new positions and closed 294 in Q2 2021.
  • UBS O'Connor's portfolio value rose 61% quarter-over-quarter to $11.2B.

Based on UBS O'Connor's 13F filing for Q2 2021, filed 13 Aug 2021.